Mast Cell Stabilizers

On this page

Intro & MOA - The Calm Keepers

  • Prophylactic anti-inflammatory agents; prevent/reduce allergic reaction severity.
  • Target mast cells, key in Type I hypersensitivity reactions.
  • Not bronchodilators; ineffective for acute asthma attacks/anaphylaxis.
  • Mechanism of Action (MOA):
    • Stabilize mast cell membranes, preventing degranulation upon allergen exposure.
    • Inhibit release of inflammatory mediators:
      • Histamine
      • Leukotrienes (e.g., LTC₄, LTD₄)
      • Prostaglandins (e.g., PGD₂)
      • Cytokines
    • Modulate delayed chloride ($Cl^−$) channels in the cell membrane, reducing $Ca^{2+}$ influx essential for exocytosis.
    • 📌 Mnemonic: "Keep the CALM": Chloride channel ALteration Mast cell stabilization.

⭐ Cromolyn sodium & Nedocromil are classic examples; primarily used for prophylaxis of mild persistent asthma, especially exercise-induced or allergen-induced asthma in children, and allergic rhinitis/conjunctivitis.

Pharmacokinetics - Journey of Stabilizers

  • Absorption (A):
    • Oral: Very poor (<1%); not for systemic use.
    • Inhalation: Main route for local lung effect. Small systemic absorption.
    • Topical: Nasal/ophthalmic for local action.
  • Distribution (D):
    • Acts locally (airways, nose, eyes). Minimal systemic distribution.
  • Metabolism (M):
    • Not metabolized; excreted unchanged.
  • Excretion (E):
    • Absorbed fraction: Urine and bile (equal).
    • Unabsorbed oral: Feces.
    • Half-life (Cromolyn): ~80-90 min.

⭐ Low systemic absorption (~8-10%) via inhalation is key, minimizing systemic adverse effects.

Key Drugs & Uses - Stabilizer Superstars

  • Cromolyn Sodium (Disodium Cromoglycate)
    • Mechanism: Stabilizes mast cell membranes, preventing degranulation and release of inflammatory mediators (histamine, leukotrienes).
    • Uses:
      • Prophylaxis of bronchial asthma (allergic, exercise-induced, irritant-induced). Not for acute bronchospasm.
      • Allergic rhinitis (nasal solution).
      • Allergic conjunctivitis (ophthalmic solution).
      • Food allergy (oral, for GI symptoms).
      • Systemic mastocytosis.
    • Dosage Forms: Metered-dose inhaler (MDI), nebulizer solution, nasal spray, eye drops (2-4%), oral capsules.
    • 📌 Mnemonic: "Cromolyn keeps mast cells from cryin' (degranulating)".
  • Nedocromil Sodium
    • Mechanism: Similar to cromolyn, inhibits mast cell degranulation and release of mediators. May also inhibit other inflammatory cells.
    • Uses:
      • Prophylaxis of mild to moderate asthma.
      • Allergic conjunctivitis (ophthalmic solution).
    • Dosage Forms: MDI, eye drops.
  • Ketotifen
    • Mechanism: Mast cell stabilizer with potent H1-antihistaminic activity.
    • Uses:
      • Long-term prophylaxis of asthma (oral).
      • Allergic rhinitis (oral, nasal spray).
      • Allergic conjunctivitis (ophthalmic solution 0.025%).
    • Dosage Forms: Tablets, syrup, eye drops, nasal spray.

⭐ Ketotifen is unique as it combines mast cell stabilizing properties with significant H1-receptor antagonism, making it particularly useful for allergic conditions with prominent itching or sneezing.

Side Effects & Cautions - Stabilizer Setbacks

  • General: Usually mild & transient.
  • Inhaled (Cromolyn, Nedocromil):
    • Common: Throat irritation, cough, bronchospasm (paradoxical).
    • Nedocromil: Unpleasant taste.
    • Headache.
  • Oral (Ketotifen):
    • Sedation (H1-blocking effect). 📌 K for Knockout.
    • Increased appetite, weight gain, dry mouth.
  • Ocular Preparations: Local irritation, stinging.
  • Serious (Rare):
    • Hypersensitivity reactions (e.g., anaphylaxis).
    • Cromolyn: Eosinophilic pneumonia, laryngeal edema.
  • Cautions & Contraindications:
    • Known hypersensitivity.
    • ⚠️ Acute asthma/bronchospasm: Ineffective; for prophylaxis ONLY.
    • Ketotifen: Caution with tasks requiring alertness (driving).
    • Abrupt withdrawal may precipitate symptoms.

⭐ Mast cell stabilizers are primarily prophylactic; they do not provide immediate relief in an acute asthma attack.

High‑Yield Points - ⚡ Biggest Takeaways

  • Mechanism: Inhibit mast cell degranulation, preventing histamine/leukotriene release.
  • Key Drugs: Cromolyn sodium, Nedocromil; Ketotifen (also H1 blocker).
  • Primary Use: Prophylaxis of allergic asthma (esp. exercise-induced) & allergic rhinitis.
  • Not for Acute Attacks: For long-term prevention, not acute relief.
  • Administration: Mainly inhalation; Ketotifen also oral/ophthalmic.
  • Safety: Excellent safety profile, minimal side effects; safe in children.
  • Onset: Slow; benefits in 2-4 weeks with regular use.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Mast Cell Stabilizers

  1. 1. Which of the following selective alpha-1 blockers can relieve lower urinary tract symptoms due to benign prostatic hyperplasia?

    • A. Prazosin
    • B. Tolazoline
    • C. Phentolamine
    • D. Phenoxybenzamine
    Show answer

    Answer: A. Prazosin

    Prazosin - Prazosin selectively blocks α1-adrenergic receptors in the prostate, prostatic urethra, and bladder neck, relaxing smooth muscle and improving urinary flow in BPH. - By reducing the dynamic component of obstruction without significant α2 blockade, prazosin is a classic alpha-blocker option for BPH, although newer α1A-selective drugs are more uroselective. Tolazoline - Tolazoline is a non-selective alpha-blocker, so it does not preferentially relax prostatic smooth muscle for chronic BPH treatment. - Its historical use in persistent pulmonary hypertension of neonates distinguishes it from the selective α1-blockers used to improve urinary flow. Phentolamine - Phentolamine is a non-selective, competitive alpha-blocker that also blocks α2 receptors, increasing norepinephrine release and causing prominent reflex tachycardia. - It is mainly used in hypertensive crises, including those associated with pheochromocytoma, rather than for long-term relief of BPH obstruction. Phenoxybenzamine has historically been used to relieve BPH symptoms through alpha-blockade. It is not the answer because it irreversibly blocks both alpha-1 and alpha-2 receptors, and its adverse effects make it less suitable than selective agents.

  2. 2. At 39 weeks, a woman with a singleton footling breech is in established labour with ruptured membranes and a cervix dilated to 4 cm. Fetal heart rate is normal. What is the most appropriate management?

    • A. Vaginal delivery
    • B. External cephalic version
    • C. Caesarean section
    • D. Expectant management
    Show answer

    Answer: C. Caesarean section

    Caesarean section is the appropriate management for this singleton footling breech in established labour with ruptured membranes. Vaginal delivery is unsuitable because footling breech carries increased risks of cord prolapse and aftercoming-head entrapment. External cephalic version is not appropriate in this stated labour and membrane setting, although 39 weeks alone would not exclude ECV. Expectant management would unnecessarily delay indicated delivery and expose the fetus to complications of footling breech.

  3. 3. Which of the following is NOT a beta-2 agonist?

    • A. Terbutaline
    • B. Ketotifen
    • C. Salbutamol
    • D. Bambuterol
    Show answer

    Answer: B. Ketotifen

    Ketotifen - Ketotifen is an oral mast cell stabilizer and H1-antihistamine, rather than a beta-2 agonist bronchodilator. - It is used for prophylaxis of asthma and allergic conditions, acting through anti-allergic mechanisms rather than direct airway smooth-muscle relaxation. Terbutaline - Terbutaline is a short-acting beta-2 agonist that relaxes airway smooth muscle, producing bronchodilation in asthma and COPD. - Its availability in oral, inhaled, and injectable forms supports its use for relief of bronchospasm, so it does not fit the “NOT” criterion. Salbutamol - Salbutamol, also called albuterol, is a short-acting beta-2 agonist commonly used as a rescue inhaler in asthma. - Stimulation of beta-2 receptors in airway smooth muscle produces rapid bronchodilation, so salbutamol is not the correct choice. Bambuterol - Bambuterol is a prodrug of terbutaline that is converted gradually to the active beta-2 agonist in the body. - Its prolonged conversion provides sustained bronchodilation for maintenance therapy, confirming that it is a beta-2 agonist rather than the exception.

  4. 4. Which of the following is NOT a mechanism of action of theophylline in bronchial asthma?

    • A. Beta-2 agonism
    • B. Phosphodiesterase inhibition
    • C. Increased histone deacetylation
    • D. Adenosine receptor antagonism
    Show answer

    Answer: A. Beta-2 agonism

    Beta-2 agonism - Theophylline does not directly stimulate beta-2 receptors; therefore, this is not one of its mechanisms of action in bronchial asthma. - Beta-2 receptor agonists such as salbutamol and formoterol produce bronchodilation by directly stimulating these receptors, unlike theophylline. Phosphodiesterase inhibition - Theophylline inhibits phosphodiesterase enzymes, increasing intracellular cAMP concentrations in airway smooth muscle. - Raised cAMP promotes airway smooth-muscle relaxation and contributes to theophylline-induced bronchodilation. Increased histone deacetylation - At lower concentrations, theophylline increases histone deacetylase activity, contributing to repression of inflammatory gene expression. - This anti-inflammatory mechanism is distinct from theophylline’s bronchodilatory effects and supports its role in asthma treatment. Adenosine receptor antagonism - Theophylline antagonizes adenosine receptors, particularly A1 and A2B receptors, which contributes to its respiratory effects. - Adenosine-receptor antagonism can reduce bronchoconstriction and inflammatory mediator release, supporting theophylline’s antiasthmatic activity.

  5. 5. Phase 1 biotransformation includes

    • A. Acetylation
    • B. Methylation
    • C. Sulfation
    • D. Reduction
    Show answer

    Answer: D. Reduction

    Reduction - Reduction is a Phase 1 biotransformation that can expose or introduce polar functional groups such as hydroxyl, amino, or sulfhydryl groups. - The principal Phase 1 reactions are oxidation, reduction, and hydrolysis, which prepare drugs for excretion or subsequent Phase 2 conjugation. Acetylation - Acetylation is a Phase 2 conjugation reaction involving transfer of an acetyl group to amine-containing drugs by N-acetyltransferase. - It does not represent Phase 1, whose reactions include oxidation, reduction, and hydrolysis that expose or introduce polar functional groups. Methylation - Methylation is classified as a Phase 2 conjugation reaction mediated by methyltransferase enzymes. - Although methylation can sometimes decrease water solubility, it remains a conjugation reaction rather than a Phase 1 transformation. Sulfation - Sulfation is a Phase 2 conjugation reaction involving sulfotransferase enzymes and addition of a sulfate group. - It is not a Phase 1 reaction; sulfation generally increases hydrophilicity and facilitates renal excretion.

  6. 6. Which of the following drugs has the LEAST cardiac side effects when used for treating an acute attack of asthma in a cardiovascular patient?

    • A. Terbutaline (short-acting beta-agonist)
    • B. Ipratropium (anticholinergic)
    • C. Formoterol (long-acting beta-agonist)
    • D. Salbutamol (short-acting beta-agonist)
    Show answer

    Answer: B. Ipratropium (anticholinergic)

    Ipratropium (anticholinergic) - Ipratropium blocks M3 muscarinic receptors in the airways, producing bronchodilation through an anticholinergic mechanism. - Its minimal systemic absorption and lack of direct cardiac stimulation give it the least cardiovascular side-effect profile among these options. Terbutaline (short-acting beta-agonist) - Terbutaline is a short-acting beta-2 agonist that produces acute bronchodilation but may also cause tachycardia and arrhythmias through systemic adrenergic effects. - Compared with ipratropium, its cardiac stimulation and potential increase in myocardial oxygen demand make it less suitable when cardiovascular effects must be minimized. Salbutamol (short-acting beta-agonist) - Salbutamol is a short-acting beta-2 agonist that is effective for acute bronchodilation but can cause palpitations and tachycardia. - Although relatively beta-2 selective, systemic exposure may produce cardiac effects, making it less favorable than ipratropium in a cardiovascular patient. Formoterol (long-acting beta-agonist) - Formoterol is a long-acting beta-2 agonist with rapid onset but prolonged action, and it is not recommended as monotherapy for an acute asthma attack. - Its prolonged beta-adrenergic stimulation can cause palpitations, tremor, or arrhythmias, so it is not the lowest-cardiac-risk choice.

  7. 7. Sago spleen is seen in which condition?

    • A. Infarction
    • B. Chronic venous congestion
    • C. Tuberculosis
    • D. Amyloidosis
    Show answer

    Answer: D. Amyloidosis

    Amyloidosis - Amyloidosis causes sago spleen when amyloid is deposited primarily in the splenic follicles, or white pulp, producing translucent, pale, 1–2 mm granules. - The sago appearance reflects tapioca-like amyloid deposits; amyloid can be confirmed by Congo red staining with apple-green birefringence under polarized light. Infarction - Infarction produces wedge-shaped, pale areas in the spleen because of occlusion of the splenic artery or its branches, rather than the characteristic granular appearance of sago spleen. - The distinguishing feature is ischemic necrosis in a vascular territory; sago spleen instead reflects amyloid deposition within splenic follicles (white pulp). Chronic venous congestion - Chronic venous congestion from portal hypertension causes congestive splenomegaly, not the translucent, tapioca-like granules characteristic of sago spleen. - Congestion may produce a siderotic spleen with Gamna-Gandy bodies, whereas sago spleen results from follicular amyloid deposition. Tuberculosis - Splenic tuberculosis typically produces multiple small, yellowish-white, firm granulomas in miliary disease or may form large cold abscesses. - These findings reflect granulomatous infection, whereas sago spleen consists of pale, translucent deposits caused by amyloid in the white pulp.

  8. 8. A 65-year-old man presents with chest pain and dyspnoea for 6 hours. Respiratory rate is 24/min with accessory muscle use, pulse 120/min, BP 150/90 mmHg, and JVP is elevated. He has acute decompensated heart failure. Which drug is contraindicated for initiation?

    • A. Heparin
    • B. Metoprolol
    • C. Morphine
    • D. Acetylsalicylic acid
    Show answer

    Answer: B. Metoprolol

    Metoprolol is the correct answer because new initiation during active acute decompensated heart failure can worsen cardiac output through negative inotropy; initiation should wait until clinical stabilization. The dyspnoea, accessory muscle use, tachypnoea, and elevated JVP support active decompensation. Heparin may be indicated for suspected acute coronary syndrome, and decompensated heart failure alone is not a contraindication. Morphine is not routine treatment but may be considered cautiously for refractory ischaemic pain; decompensated heart failure alone is not an absolute contraindication. Acetylsalicylic acid is antiplatelet treatment for suspected acute coronary syndrome, and decompensated heart failure is not a contraindication.

  9. 9. Riociguat is used in the treatment of:

    • A. Systemic arterial hypertension
    • B. Acute pulmonary embolism
    • C. Pulmonary hypertension due to veno-occlusive disease
    • D. Chronic thromboembolic pulmonary hypertension
    Show answer

    Answer: D. Chronic thromboembolic pulmonary hypertension

    Chronic thromboembolic pulmonary hypertension is the correct indication, specifically inoperable disease or persistent or recurrent disease after endarterectomy. Riociguat stimulates soluble guanylate cyclase and increases cGMP. Systemic arterial hypertension is not an established treatment indication for riociguat. Acute pulmonary embolism requires appropriate antithrombotic treatment rather than riociguat as treatment of the acute embolus. Pulmonary hypertension due to veno-occlusive disease is not an established indication, and pulmonary vasodilators can precipitate pulmonary oedema in this condition.

  10. 10. A 42-year-old man was seen in the clinic because of pain and redness in his finger. Last week he had injured the finger while working in his garage. On physical examination, there is erythema, swelling, and tenderness of the second digit in the right hand. Flexion and extension of the finger were normal. A clinical diagnosis of cellulitis is made and he is prescribed cephalexin. A few days later he presents to the emergency room complaining of difficulty breathing. He has angioedema due to a drug reaction to the cephalexin. Which of the following physical findings is characteristic of this syndrome?

    • A. Invariably severe itching
    • B. Prolonged nature of the edema
    • C. Fluid extravasation from subcutaneous and intradermal postcapillary venules
    • D. Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet
    Show answer

    Answer: D. Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet

    Involvement of lips, tongue, eyelids, genitalia, and dorsum of hands or feet - Angioedema characteristically causes localized swelling of the lips, tongue, eyelids, genitalia, and dorsum of the hands or feet. - These sites contain relatively loose connective tissue, allowing substantial fluid accumulation during deeper dermal and subcutaneous edema. Invariably severe itching - Severe itching is not invariably present in angioedema; pruritus is more typical of urticaria, which affects the superficial dermis. - Bradykinin-mediated angioedema often produces deep swelling with absent or minimal itching, distinguishing it from intensely pruritic wheals. Fluid extravasation from subcutaneous and intradermal postcapillary venules - Fluid extravasation from postcapillary venules occurs in both urticaria and angioedema, so it is not the most distinctive physical finding here. - In angioedema, extravasated fluid accumulates mainly in the deep dermis and subcutaneous tissue, whereas urticaria involves more superficial tissue. Prolonged nature of the edema - Angioedema is usually episodic and self-limiting, with edema commonly resolving within approximately 24 to 72 hours rather than persisting for prolonged periods. - The typically transient duration helps distinguish angioedema from chronic inflammatory or persistent edematous conditions, although recurrence may occur.

Flashcards: Mast Cell Stabilizers

  1. 1. is a systemic steroid used for maintenance therapy after an acute exacerbation of asthma.

    Show answer

    Prednisolone

  2. 2. In an asthmatic response, mast cells lead to generation of leukotrienes _____, _____, and _____ (early-phase reaction)

    Show answer

    C4 · D4 · E4

  3. 3. Selective _____ agonists, such as albuterol, treat _____ in asthma

    Show answer

    beta-2 · bronchoconstriction

  4. 4. What is recommended as regular therapy for the prevention of symptoms of exercise-induced asthma?

    Show answer

    Inhaled corticosteroids

  5. 5. Which classes of drugs are used to treat asthma by blocking inflammation (late response)? _____, _____

    Show answer

    Inhaled corticosteroids · anti-leukotrienes

  6. 6. Asthma _____ is a monoclonal antibody directed against the _____ portion of _____, preventing mast cell sensitization

    Show answer

    Omalizumab · Fc · IgE

  7. 7. Adverse effects of non-selective beta-blockers include exacerbation of _____ and _____

    Show answer

    asthma · COPD

  8. 8. Ipratropium is a competitive _____ receptor antagonist that is used to prevent _____ in asthmatic and COPD patients

    Show answer

    M3 · bronchoconstriction

  9. 9. Corticosteroids treat asthma by blocking _____ and _____

    Show answer

    inflammation · cellular infiltration

  10. 10. _____ is a monoclonal antibody against _____ used for maintenance therapy for asthma.

    Show answer

    Benralizumab · IL-5 receptor alpha

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF